Efficacy and Safety of MW031 in PMO Subjects

NCT05215977 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: MW031
DRUG: Placebo

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.